DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Subscribe to see Delfi Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Delfi Diagnostics, Inc. is a diagnostics company headquartered in United States. It has raised at least $365.9M across the 5 funding rounds on record. Its most recent funding round raised $34.3M in December 2025. Xcout tracks 36 named people at Delfi Diagnostics, Inc., including Susan Tousi (Chief Executive Officer). Xcout recorded 14 job postings from Delfi Diagnostics, Inc. in the last 90 days, naming tools such as Palo Alto Networks.
30 more named people on record for Delfi Diagnostics, Inc., with roles, board committees and tenure — see the full roster →
At least $365.9M raised across the 5 rounds on record. The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $34.3M | — | |
| Series B | $225M | 13 named | |
| — | $101.1M | 13 named | |
| SEC Form D filing | $5.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 14 job postings from Delfi Diagnostics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Delfi Diagnostics, Inc.'s hiring signals →
A few of Delfi Diagnostics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Identifai Genetics is a clinical-stage biotechnology and health tech company developing advanced prenatal screening tests using AI, machine learning, and whole genome analysis. It is headquartered in Rosh Haayin, Israel.
PhiTech is a TechBio biotechnology company headquartered in Gebze, Kocaeli, Turkey. The firm leads a global shift from DNA-only diagnostics to AI-powered multi-omics, establishing new standards for precision medicine. Utilizing advanced bioinformatics and decision analysis, the company develops cutting-edge diagnostic tools.
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Day Zero Diagnostics, Inc. is a Boston-based company founded in 2016 that is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to address antibiotic resistance.
Inocras Inc. is a bioinformatics-led biotechnology company headquartered in San Diego, California. The firm utilizes whole genome data and proprietary artificial intelligence analytics to deliver curated genomic care.
Nexosome Oncology Holdings, Inc. develops blood tests for early-stage cancer detection using patented extracellular vesicle proteomics and AI/ML biomarker discovery. The company serves patients and healthcare partners by providing highly accurate diagnostic tools.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Delfi Diagnostics, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.